Patients play a vital role in finding better ways to treat cancer by participating in clinical trials. Thanks to patients who volunteered for studies, we now have a range of treatments that can cure or delay the progression of cancer for many years. Our patients are partners in care and partners in discovery.
As national leaders in the field, the University of Michigan Comprehensive Cancer Center's Skin Cancer Program provides care that builds on research and decades of outstanding success rates in the healing of all types of skin cancer -- melanoma, basal and squamous cell carcinomas, and Merkel cell carcinomas.
Over the past 30 years -- and through hundreds of clinical trials -- we've discovered better treatments so there's less chance of cancer coming back. With the help of clinical trials, we've also learned better methods of detecting cancer -- catching it earlier, when we have the best chance of curing it.
More than 190,000 women will be diagnosed with breast cancer this year. But only 5-10% of those breast cancers are caused by an inherited genetic mutation. The same gene can put women at a higher risk of ovarian cancer as well.
At the University of Michigan Comprehensive Cancer Center, doctors and scientists are committed to discovering new forms of treatment for head and neck cancer. By using the latest surgical techniques and incorporating the newest laboratory discoveries, we are able to preserve and rebuild the tissues of the mouth and throat so our patients can return to their daily lives with excellent function and quality of life.
Clinical research is a partnership between doctors and patients working to improve the treatment of cancer. Being in a clinical trial can mean trying new medicines to understand them better. Research can also mean comparing two types of cancer treatment to see which one is most effective. The ultimate goal of all clinical trials is to cure cancer and improve quality of life.
The collaborative spirit is at work here, allowing doctors and scientists to assist each other in advancing us toward better and more effective treatments for cancer. Be part of our progress. Be part of the Michigan Difference.
Adrenal cancer is rare. Exceptional patient care and innovative treatment strategies for adrenal cancer shouldn't be. At the University of Michigan Comprehensive Cancer Center, we apply the same multidisciplinary approach to diagnosing and treating adrenal cancer, and the same translational approach to basic and clinical research in the field, as we do for more prevalent cancer types.
December is Cancer-Related Fatigue Awareness Month
Cancer-related fatigue is the most common side effect of cancer and cancer treatment. Research suggests that anywhere between 70% and 100% of cancer
patients getting treatment have fatigue. There are things you can do to manage and reduce your fatigue
Learn more.
Quality and Safety website
Provides recently updated information on cancer care.
Blue Cross Blue Shield of Michigan honored for programs to improve patient care
A Cancer Center team coordinates one of the award-winning research collaboratives.
A Reason to Celebrate
Tips for getting through this busy season.
Quality and Safety website
Many hospitals and medical providers claim they do a great job at caring for cancer patients and protecting their safety during care. We've recently updated the quality and safety website with
facts about how many procedures we perform and how successful they were.
Learn more.
Blue Cross Blue Shield of Michigan honored for programs to improve patient care
A Cancer Center team coordinates one of the award-winning research collaboratives.
A Reason to Celebrate
Tips for getting through this busy season.
Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments
Offers hope for those with treatment-resistent cancer.
Blue Cross Blue Shield of Michigan honored for programs to improve patient care
U-M Comprehensive Cancer Center team coordinates award-winning research collaborative to improve pain and symptom management for Michigan cancer
patients. This collaboration, the Quality Oncology Practice Consortium, earned a clinical distinction award.
Learn more.
A Reason to Celebrate
Tips for getting through this busy season.
Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments
Offers hope for those with treatment-resistent cancer.
U-M researchers find genetic rearrangements driving 5% to 7% of breast cancers
The discovery may lead to a more personalized treatment of breast cancer.
A Reason to Celebrate
From Thanksgiving to New Year's Day, the holiday season can be daunting under even the best circumstances. But people coping with cancer face
different stresses. We've assembled tips from patients, parents, survivors and social workers about how to make the best of the season.
Learn more.
Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments
Offers hope for those with treatment-resistent cancer.
U-M researchers find genetic rearrangements driving 5% to 7% of breast cancers
The discovery may lead to a more personalized treatment of breast cancer.
Fall issue of Thrive is online
Learn about patient engagement and managing symptoms.
